✨ Medicines Consent Notices
530
NEW ZEALAND GAZETTE
No. 23
Dated this 21st day of February 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1380
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Rescriptor
Active Ingredient(s):
Delavirdine mesylate 100mg equivalent to 82.6mg delavirdine base
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer Laboratories Limited
Manufacturer(s):
Pharmacia Inc, Barcelonetta, Puerto Rico
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 21st day of February 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1379
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Avaxim
Active Ingredient(s):
Hepatitis A virus formaldehyde inactivated (GBM strain) 160U
Dosage Form:
Suspension for injection
New Zealand Sponsor:
CSL (New Zealand) Limited
Manufacturer(s):
Aventis Pasteur SA, Marcy L’Etoile, France
Product:
Biostate
Active Ingredient(s):
Dried factor VIII fraction 250IU
Dosage Form:
Powder for injection
New Zealand Sponsor:
CSL (New Zealand) Limited
Manufacturer(s):
CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia
Product:
Cefazolin Injection
Active Ingredient(s):
Cephazolin sodium 524mg equivalent to 0.5g cefazolin
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Biochemie GmbH, Kundl, Austria
Product:
Cefazolin Injection
Active Ingredient(s):
Cephazolin sodium 1,048mg equivalent to 1g cefazolin
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Biochemie GmbH, Kundl, Austria
Product:
Cefotaxime Sodium for Injection
Active Ingredient(s):
Cefotaxime sodium 1.048g equivalent to 1g cefotaxime
Dosage Form:
Powder for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer(s):
Anfarm Hellas SA, Athens, Greece
Product:
Cefotaxime Sodium for Injection
Active Ingredient(s):
Cefotaxime sodium 2.096g equivalent to 2g cefotaxime
Dosage Form:
Powder for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer(s):
Anfarm Hellas SA, Athens, Greece
Product:
Cefotaxime Sodium for Injection
Active Ingredient(s):
Cefotaxime sodium 525mg equivalent to 500mg cefotaxime
Dosage Form:
Powder for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer(s):
Anfarm Hellas SA, Athens, Greece
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 23
Gazette.govt.nz —
NZ Gazette 2001, No 23
✨ LLM interpretation of page content
🏥 Provisional Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare21 February 2001
Medicines, Provisional Consent, Rescriptor, Delavirdine mesylate
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare21 February 2001
Medicines, Consent, Avaxim, Biostate, Cefazolin Injection, Cefotaxime Sodium for Injection
- G. R. Boyd, Chief Advisor, Safety and Regulation